Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mehlen

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
Plos Biology|May 12, 2018
Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growthMarie Ménard, Clélia Costechareyre, Gabriel Ichim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2007
The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigmServane Tauszig-Delamasure, Li-Ying Yu, Jorge Ruben Cabrera, et al.
Cell Death & Disease|February 28, 2023
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancerSonia Brahim, Ana-Maria Negulescu, Clara Geneste, et al.
Bulletin Du Cancer|January 14, 2020
Frédéric Catez, Nicole Dalla-Venezia, Jean-Jacques Diaz, et al.
Nature Communications|July 19, 2017
Non-canonical NOTCH3 signalling limits tumour angiogenesisShuheng Lin, Ana Negulescu, Sirisha Bulusu, et al.
Plos Genetics|September 26, 2017
p53-dependent programmed necrosis controls germ cell homeostasis during spermatogenesisFrancesco Napoletano, Benjamin Gibert, Keren Yacobi-Sharon, et al.
Nucleic Acids Research|May 27, 2015
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cellsGuillaume Devailly, Mélodie Grandin, Laury Perriaud, et al.
Nature|December 14, 2011
DCC constrains tumour progression via its dependence receptor activityMarie Castets, Laura Broutier, Yann Molin, et al.
Cancer Research|December 7, 2019
Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma ProgressionAmina Boussouar, Antonin Tortereau, Ambroise Manceau, et al.
Theranostics|November 16, 2018
Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancerJennifer Wischhusen, Katheryne E Wilson, Jean-Guy Delcros, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Plos Biology|May 12, 2018
Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growthMarie Ménard, Clélia Costechareyre, Gabriel Ichim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2007
The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigmServane Tauszig-Delamasure, Li-Ying Yu, Jorge Ruben Cabrera, et al.
Cell Death & Disease|February 28, 2023
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancerSonia Brahim, Ana-Maria Negulescu, Clara Geneste, et al.
Bulletin Du Cancer|January 14, 2020
Frédéric Catez, Nicole Dalla-Venezia, Jean-Jacques Diaz, et al.
Nature Communications|July 19, 2017
Non-canonical NOTCH3 signalling limits tumour angiogenesisShuheng Lin, Ana Negulescu, Sirisha Bulusu, et al.
Plos Genetics|September 26, 2017
p53-dependent programmed necrosis controls germ cell homeostasis during spermatogenesisFrancesco Napoletano, Benjamin Gibert, Keren Yacobi-Sharon, et al.
Nucleic Acids Research|May 27, 2015
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cellsGuillaume Devailly, Mélodie Grandin, Laury Perriaud, et al.
Nature|December 14, 2011
DCC constrains tumour progression via its dependence receptor activityMarie Castets, Laura Broutier, Yann Molin, et al.
Cancer Research|December 7, 2019
Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma ProgressionAmina Boussouar, Antonin Tortereau, Ambroise Manceau, et al.
Theranostics|November 16, 2018
Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancerJennifer Wischhusen, Katheryne E Wilson, Jean-Guy Delcros, et al.
Pageof 16